AU2902289A - Method of forming bioerodible implants for improved controlled drug release - Google Patents

Method of forming bioerodible implants for improved controlled drug release

Info

Publication number
AU2902289A
AU2902289A AU29022/89A AU2902289A AU2902289A AU 2902289 A AU2902289 A AU 2902289A AU 29022/89 A AU29022/89 A AU 29022/89A AU 2902289 A AU2902289 A AU 2902289A AU 2902289 A AU2902289 A AU 2902289A
Authority
AU
Australia
Prior art keywords
forming
method
drug release
controlled drug
improved controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29022/89A
Inventor
Mark Chasin
Original Assignee
Mark Chasin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13019387A priority Critical
Priority to US130193 priority
Application filed by Mark Chasin filed Critical Mark Chasin
Publication of AU2902289A publication Critical patent/AU2902289A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G67/00Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing oxygen or oxygen and carbon, not provided for in groups C08G2/00 - C08G65/00
    • C08G67/04Polyanhydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
AU29022/89A 1987-12-08 1988-12-06 Method of forming bioerodible implants for improved controlled drug release Abandoned AU2902289A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13019387A true 1987-12-08 1987-12-08
US130193 1987-12-08

Publications (1)

Publication Number Publication Date
AU2902289A true AU2902289A (en) 1989-07-05

Family

ID=22443495

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29022/89A Abandoned AU2902289A (en) 1987-12-08 1988-12-06 Method of forming bioerodible implants for improved controlled drug release

Country Status (2)

Country Link
AU (1) AU2902289A (en)
WO (1) WO1989005138A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997904A (en) * 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
US5525348A (en) * 1989-11-02 1996-06-11 Sts Biopolymers, Inc. Coating compositions comprising pharmaceutical agents
DK0626854T3 (en) * 1990-07-12 1999-04-19 Sts Biopolymers Inc The anti-thrombogenic and / or anti-microbial composition
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US5989463A (en) * 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying drug formulation and use of this formulation
US7658998B2 (en) 2003-01-22 2010-02-09 Alkermes Controlled Therapeutics, Inc. Method of preparing sustained release microparticles
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20070292470A1 (en) * 2006-06-15 2007-12-20 Medtronic Vascular, Inc. Implantable Medical Devices and Methods for Making the Same
WO2013124869A2 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
DE3413608A1 (en) * 1984-04-11 1985-10-24 Hoechst Ag Implantable preparations of regulatory peptides with controlled release and process for their manufacture
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time

Also Published As

Publication number Publication date
WO1989005138A1 (en) 1989-06-15

Similar Documents

Publication Publication Date Title
US5000685B1 (en) Spacer for dental implants
US5087200B1 (en) Spacer for dental implants
AU637455B2 (en) Apparatus for preparation of a prosthesis
AU589899B2 (en) Implant and method for production thereof
AU558688B2 (en) Treated collagen prosthetic implant
AU624620B2 (en) Method for the preparation of tetrahydrofolates
GB2208606B (en) Penile prosthesis
AU610207B2 (en) Method for priming hard tissue
AU655162B2 (en) Lipospheres for controlled delivery of substances
GB2218905B (en) Controlled release pharmaceutical
EP0314863A3 (en) Method of treatment for non-specific inflammation
EP0741580A4 (en) Controlled release of pharmaceutically active substances for immunotherapy
HUT49571A (en) Process for producing substituted pyrrol-, pyrazol- and triazol derivatives and pharmaceutical compositions containing them
AU3281493A (en) Surface hardened biocompatible metallic medical implants
EP0489843A4 (en) Bioerodible polymers useful for the controlled release of therapeutic agents
PT88361A (en) Method for the preparation of improved implants with antimicrobial coating
AU3918889A (en) Hirudin-coated biocompatible substance
GR3001657T3 (en) Acetabular cup prosthesis
EP0251680A3 (en) Controlled release bioerodible drug delivery system
PL272698A1 (en) Method for expressing human proapolyprotein a-j
SI9011847B (en) Process for the preparation of the oestrogen-containing active substance plaster
IE891006L (en) Controlled release pharmaceutical preparation
IL87913A (en) Adjustable prosthesis
AU7962487A (en) Bone graft implant
EP0292026A3 (en) A method for producing prosthetic constructions